Logo


Optimising the patient journey


Find out how improved diagnosis could lead to improved prognosis.


Patient journey

Individuals diagnosed with AL amyloidosis have a wide range of experiences. Take a look at this hypothetical journey of a patient, and then see the potential impact improved awareness and cross-disciplinary collaboration could have made.

Current journey
Improved awareness journey

A patient with AL amyloidosis

ig-current-patient-journey

2+ YEARS TO IDENTIFY


which impacts both morbidity and mortality[1]

NT-proBNP=N-terminal pro-B-type natriuretic peptide

Working together for improved prognosis

What are the current treatments and techniques to manage patients with AL amyloidosis? In this short 4-minute video, Dr Vaishali Sanchorawala (haematology/oncology) and Dr Omar Siddiqi (cardiology) discuss the importance of multidisciplinary collaboration in the decision-making process in order to transform AL amyloidosis into a manageable chronic condition.

Learn about AL amyloidosis
Learn about the steps involved in diagnosing patients with AL amyloidosis

Download this information on AL amyloidosis

References

Palladini G, et al. Haematologica. 2014;99(4):743–50.
CP-255639 - September 2021